View in EDS

Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children.

Saved in:
Bibliographic Details
Title: Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children.
Authors: Kawade A; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India. Electronic address: anand.kawade@kemhrcvadu.org., Dayma G; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India., Apte A; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India., Telang N; Department of Microbiology, KEM Hospital, Pune, India., Satpute M; Department of Microbiology, KEM Hospital, Pune, India., Pearce E; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Roalfe L; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Patil R; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India., Wang Y; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Noori N; Institute for Disease Modeling, Global Health Division, Bill and Melinda Gates Foundation, 500 5th Ave N, Seattle, WA, USA., Gondhali A; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India., Juvekar S; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India., Oron AP; Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA., Sanghavi S; Department of Microbiology, KEM Hospital, Pune, India., Goldblatt D; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Dagan R; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Bavdekar A; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India. Electronic address: a.bavdekar@kemhrcpune.org.
Source: Vaccine [Vaccine] 2023 May 05; Vol. 41 (19), pp. 3066-3079. Date of Electronic Publication: 2023 Apr 10.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37045679
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix<superscript>TM</superscript> and Prevenar13<superscript>TM)</superscript>) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kawade+A%22">Kawade A</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India. Electronic address: anand.kawade@kemhrcvadu.org.<br /><searchLink fieldCode="AU" term="%22Dayma+G%22">Dayma G</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India.<br /><searchLink fieldCode="AU" term="%22Apte+A%22">Apte A</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India.<br /><searchLink fieldCode="AU" term="%22Telang+N%22">Telang N</searchLink>; Department of Microbiology, KEM Hospital, Pune, India.<br /><searchLink fieldCode="AU" term="%22Satpute+M%22">Satpute M</searchLink>; Department of Microbiology, KEM Hospital, Pune, India.<br /><searchLink fieldCode="AU" term="%22Pearce+E%22">Pearce E</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Roalfe+L%22">Roalfe L</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patil+R%22">Patil R</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Noori+N%22">Noori N</searchLink>; Institute for Disease Modeling, Global Health Division, Bill and Melinda Gates Foundation, 500 5th Ave N, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Gondhali+A%22">Gondhali A</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India.<br /><searchLink fieldCode="AU" term="%22Juvekar+S%22">Juvekar S</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India.<br /><searchLink fieldCode="AU" term="%22Oron+AP%22">Oron AP</searchLink>; Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA.<br /><searchLink fieldCode="AU" term="%22Sanghavi+S%22">Sanghavi S</searchLink>; Department of Microbiology, KEM Hospital, Pune, India.<br /><searchLink fieldCode="AU" term="%22Goldblatt+D%22">Goldblatt D</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dagan+R%22">Dagan R</searchLink>; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Bavdekar+A%22">Bavdekar A</searchLink>; Vadu Rural Health Program, KEM Hospital Research Centre, Pune, India. Electronic address: a.bavdekar@kemhrcpune.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2023 May 05; Vol. 41 (19), pp. 3066-3079. <i>Date of Electronic Publication: </i>2023 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37045679
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2023.04.008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3066
    Titles:
      – TitleFull: Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kawade A
      – PersonEntity:
          Name:
            NameFull: Dayma G
      – PersonEntity:
          Name:
            NameFull: Apte A
      – PersonEntity:
          Name:
            NameFull: Telang N
      – PersonEntity:
          Name:
            NameFull: Satpute M
      – PersonEntity:
          Name:
            NameFull: Pearce E
      – PersonEntity:
          Name:
            NameFull: Roalfe L
      – PersonEntity:
          Name:
            NameFull: Patil R
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Noori N
      – PersonEntity:
          Name:
            NameFull: Gondhali A
      – PersonEntity:
          Name:
            NameFull: Juvekar S
      – PersonEntity:
          Name:
            NameFull: Oron AP
      – PersonEntity:
          Name:
            NameFull: Sanghavi S
      – PersonEntity:
          Name:
            NameFull: Goldblatt D
      – PersonEntity:
          Name:
            NameFull: Dagan R
      – PersonEntity:
          Name:
            NameFull: Bavdekar A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 05
              Text: 2023 May 05
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1